Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain

被引:26
|
作者
Hendriks, L
De Jonghe, C
Lübke, U
Woodrow, S
Vanderhoeven, I
Boons, J
Cras, P
Martin, JJ
Van Broeckhoven, C
机构
[1] Univ Antwerp VIB, Neurogenet Lab, Dept Biochem, B-2610 Antwerp, Belgium
[2] Univ Antwerp, Neuropathol Lab, B-2610 Antwerp, Belgium
[3] Univ Antwerp, Neurobiol Lab, Dept Med, Born Bunge Fdn, B-2610 Antwerp, Belgium
关键词
Alzheimer's disease; immunohistochemistry; polyclonal antibody; presenilin-1; tau;
D O I
10.1006/exnr.1997.6739
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mutations in the presenilin-1 gene (PS-1) on chromosome 14 are causative for early-onset familial Alzheimer's disease (AD). In order to study the localization of PS-1 in human brain, a polyclonal antibody, SB63, against a N-terminal epitope of PS-1 ((25)VRSQNDNRER-QEHND(40)), was raised in rabbits and characterized. Immunolabeling with SB63 of formalin-fixed sections of hippocampus from cases of PS-1-linked AD (PS-1 I143T (AD/A), G384A (AD/B)), sporadic AD, and controls showed a predominant neuronal staining pattern with a stronger immunoreactivity in pyramidal neurons. Staining was mainly granular and localized in the neuronal cell body as well as in neuronal processes. In AD some dystrophic neurites surrounding the amyloid plaques were stained, but no immunoreactivity was observed in the amyloid core. Although PS-1 was present in tangle bearing neurons, colocalization of PS-1 and tau could not be detected using immunofluorescence double labeling. Our data indicate that the pattern of PS-1 immunoreactivity in the hippocampus does not substantially differ between PS-1-linked AD, sporadic AD, and controls. (C) 1998 Academic Press.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 50 条
  • [1] Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques
    Weber, LL
    Leissring, MA
    Yang, AJ
    Glabe, CG
    Cribbs, DH
    LaFerla, FM
    [J]. EXPERIMENTAL NEUROLOGY, 1997, 143 (01) : 37 - 44
  • [2] Presenilin-1 polymorphism and Alzheimer's disease
    Higuchi, S
    Muramatsu, T
    Matsushita, S
    Arai, H
    Sasaki, H
    [J]. LANCET, 1996, 347 (9009): : 1186 - 1186
  • [3] Presenilin-1 mutations in Alzheimer's disease
    C. Russo
    G. Schettini
    T. C. Saido
    C. Hulette
    C. Lippa
    L. Lannfelt
    B. Ghetti
    P. Gambetti
    M. Tabaton
    J. K. Teller
    [J]. Nature, 2000, 405 : 531 - 532
  • [4] Presenilin-1 polymorphism and Alzheimer's disease
    Scott, WK
    Roses, AD
    Haines, JL
    PericakVance, MA
    [J]. LANCET, 1996, 347 (9014): : 1560 - 1560
  • [5] Presenilin-1 polymorphism and Alzheimer's disease
    Owen, MJ
    Kehoe, P
    Williams, J
    [J]. LANCET, 1996, 348 (9024): : 414 - 414
  • [6] Presenilin-1 mutations and Alzheimer's disease
    Kelleher, Raymond J., III
    Shen, Jie
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (04) : 629 - 631
  • [7] Plaque pathology in presenilin-1 Alzheimer's disease
    Shepherd, C
    Gregory, G
    McCann, H
    Halliday, G
    Kwok, J
    Schofield, P
    Kril, J
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S220 - S220
  • [8] Alteration in brain presenilin-1 mRNA expression in sporadic Alzheimer's disease
    Isoe-Wada, K
    Urakami, K
    Wakutani, Y
    Adachi, Y
    Arai, H
    Sasaki, H
    Nakashima, K
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (02) : 163 - 167
  • [9] Presenilin-1 gene mutations in Alzheimer's disease
    Mann, DMA
    [J]. BRAIN PATHOLOGY, 2000, 10 (04) : 713 - 713
  • [10] Neurobiology - Presenilin-1 mutations in Alzheimer's disease
    Russo, C
    Schettini, G
    Saido, TC
    Hulette, C
    Lippall, C
    Lannfelt, L
    Ghetti, B
    Gambetti, P
    Tabaton, M
    Teller, JK
    [J]. NATURE, 2000, 405 (6786) : 531 - 532